Lepodisiran Reduces Lipoprotein(a) By Nearly 94% in Adults With Elevated Levels of Lp(a)

Source: Pharmacy Times articles

Lepodisiran, a small interfering RNA, demonstrated cholesterol-lowering effects at 16-mg, 96-mg, and 400-mg doses, with the highest dose being the most effective.
Read More